A resolution designating September 25, 2025, as "National Ataxia Awareness Day", and raising awareness of ataxia, ataxia research, and the search for a cure.
- Bill Number
- S.Res. 447
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Passed Senate
- Latest Action
- 2025-10-09: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S7101; text: CR S7097)
- Last Updated
- 2026-06-16T16:31:10Z
AI-Generated Summary
Purpose
This Senate resolution aims to increase public awareness of ataxia—a group of rare neurodegenerative diseases that affect movement coordination—by designating September 25, 2025, as "National Ataxia Awareness Day." It emphasizes the challenges faced by those affected, the need for better diagnosis and care, and the importance of ongoing research toward treatments and a cure.
Key Provisions
- Background on Ataxia: The resolution describes ataxia as a condition caused by brain degeneration or dysfunction, leading to impaired coordination and movement. It affects people of all ages, including children, and includes various types such as ataxia telangiectasia, episodic ataxia, Friedreich's ataxia, and spinocerebellar ataxia. These are rare diseases (affecting fewer than 200,000 people in the U.S.), recognized under the Orphan Drug Act, which provides incentives for developing treatments for uncommon conditions.
- Causes and Symptoms: Ataxia can be inherited (genetically, in dominant or recessive patterns) or result from non-genetic factors like stroke, tumors, cerebral palsy (a disorder affecting muscle control and movement), head injuries, multiple sclerosis (an autoimmune disease damaging the nervous system), alcohol misuse, or certain medications. Symptoms vary but may include lack of coordination, slurred speech, heart muscle disease (cardiomyopathy), spine curvature (scoliosis), eye movement issues, walking difficulties, tremors, swallowing problems, challenges with fine motor skills, and potentially death.
- Challenges and Needs: It highlights physical, emotional, and financial burdens on patients and families, the frequent need for mobility aids (like wheelchairs or walkers), therapy, and the lack of approved cures or many treatments. Research for safe and effective options is ongoing.
- Actions by the Senate:
- Recognizes the need for greater awareness of ataxia.
- Officially designates September 25, 2025, as National Ataxia Awareness Day.
- Supports the day's goals: raising awareness of causes and symptoms among the public and healthcare providers; improving diagnosis and access to care; and speeding up research for treatments and a cure.
- Acknowledges the struggles of individuals with ataxia and their families in the U.S.
- Encourages states, territories, and local communities to promote the day's objectives.
Significant Changes to Existing Law
This is a non-binding resolution with no legal force, so it introduces no changes to existing laws or statutes. It builds on prior recognition of rare diseases under the Orphan Drug Act but does not amend it.
Potential Impacts
- On Citizens: May increase public education about ataxia, leading to earlier diagnoses, better support for affected individuals and families, and more advocacy for research funding. It could indirectly encourage participation in clinical trials and access to therapies.
- On Government Agencies: No direct mandates, but it may prompt federal health agencies (like the National Institutes of Health) to highlight ataxia in public campaigns or research priorities. States and localities are encouraged—but not required—to participate in awareness efforts.
- On International Relations: Minimal to none, as the resolution is U.S.-focused and does not address global policy or cooperation.
Main Stakeholders Affected
- Individuals with Ataxia and Their Families: Primary beneficiaries through heightened visibility and potential improvements in care and research.
- Healthcare Professionals: Encouraged to better recognize and diagnose ataxia.
- Researchers and Medical Community: Supported in efforts to advance treatments and cures for these rare diseases.
- Advocacy Groups and Nonprofits: Likely to use the designated day for events and fundraising.
- State and Local Governments: Urged to support awareness initiatives, potentially through public health programs.
Notable Legal, Constitutional, or Political Implications
- Legal: As a simple resolution agreed to by the Senate, it has no enforceable effect and requires no presidential approval. It aligns with congressional authority to pass non-binding measures for awareness (under Article I of the Constitution, which grants legislative powers).
- Constitutional: No implications, as it does not infringe on rights or allocate funds.
- Political: Demonstrates bipartisan support (introduced by Senators from both parties) for rare disease advocacy, potentially influencing future funding bills or health policy discussions. It underscores the Senate's role in promoting public health without controversy.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (2)
Sen. Murphy, Christopher [D-CT], Sen. Capito, Shelley Moore [R-WV]
Recent Actions
- 2025-10-09: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S7101; text: CR S7097)
- 2025-10-09: Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.
- 2025-10-09: Introduced in Senate
Bill Versions
- Designating September 25, 2025, as National Ataxia Awareness Day, and raising awareness of ataxia, ataxia research, and the search for a cure. — issued 2025-10-09 — PDF (4 pages)